Free Trial

Viemed Healthcare (VMD) Stock Price, News & Analysis

Viemed Healthcare logo
$9.84 -0.17 (-1.70%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$9.82 -0.03 (-0.25%)
As of 05/29/2026 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Viemed Healthcare Stock (NASDAQ:VMD)

Advanced

Key Stats

Today's Range
$9.81
$10.03
50-Day Range
$8.52
$10.05
52-Week Range
$5.93
$10.18
Volume
278,673 shs
Average Volume
256,676 shs
Market Capitalization
$377.24 million
P/E Ratio
26.59
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Viemed Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

VMD MarketRank™: 

Viemed Healthcare scored higher than 61% of companies evaluated by MarketBeat, and ranked 402nd out of 870 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Viemed Healthcare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Viemed Healthcare has received no research coverage in the past 90 days.

  • Read more about Viemed Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Viemed Healthcare are expected to grow by 31.82% in the coming year, from $0.44 to $0.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Viemed Healthcare is 26.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.19.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Viemed Healthcare is 26.59, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.40.

  • Price to Book Value per Share Ratio

    Viemed Healthcare has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Viemed Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    1.33% of the float of Viemed Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Viemed Healthcare has a short interest ratio ("days to cover") of 1.31, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Viemed Healthcare has recently decreased by 8.61%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Viemed Healthcare does not currently pay a dividend.

  • Dividend Growth

    Viemed Healthcare does not have a long track record of dividend growth.

  • News Sentiment

    Viemed Healthcare has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.83 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Viemed Healthcare this week, compared to 1 article on an average week.
  • Search Interest

    2 people have searched for VMD on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Viemed Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Viemed Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,237,976.00 in company stock.

  • Percentage Held by Insiders

    20.00% of the stock of Viemed Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    74.24% of the stock of Viemed Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Viemed Healthcare's insider trading history.
Receive VMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viemed Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VMD Stock News Headlines

Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
Viemed Healthcare's Earnings: A Preview
See More Headlines

VMD Stock Analysis - Frequently Asked Questions

Viemed Healthcare's stock was trading at $7.43 at the start of the year. Since then, VMD stock has increased by 32.4% and is now trading at $9.84.

Viemed Healthcare, Inc. (NASDAQ:VMD) posted its quarterly earnings results on Tuesday, May, 5th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by $0.03. The business earned $75.41 million during the quarter, compared to analysts' expectations of $74.40 million. Viemed Healthcare had a net margin of 5.20% and a trailing twelve-month return on equity of 10.52%.
Read the conference call transcript
.

Viemed Healthcare's top institutional investors include Arrowstreet Capital Limited Partnership (1.85%), Punch & Associates Investment Management Inc. (1.40%), Renaissance Technologies LLC (1.15%) and Lazard Asset Management LLC (0.56%). Insiders that own company stock include Michael Moore, Nitin Kaushal, Randy E Dobbs, Jerome Cambre, Timothy Smokoff and Sabrina Heltz.
View institutional ownership trends
.

Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Viemed Healthcare investors own include Myomo (MYO), Alpha Teknova (TKNO), Heron Therapeutics (HRTX), Advanced Micro Devices (AMD), Zevra Therapeutics (ZVRA) and Enterprise Products Partners (EPD).

Company Calendar

Last Earnings
5/05/2026
Today
5/30/2026
Next Earnings (Estimated)
8/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Healthcare
Current Symbol
NASDAQ:VMD
CIK
1729149
Fax
N/A
Employees
1,382
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
$0.37
Trailing P/E Ratio
26.59
Forward P/E Ratio
22.36
P/E Growth
N/A
Net Income
$14.93 million
Net Margins
5.20%
Pretax Margin
7.71%
Return on Equity
10.52%
Return on Assets
7.60%

Debt

Debt-to-Equity Ratio
0.06
Current Ratio
1.22
Quick Ratio
1.10

Sales & Book Value

Annual Sales
$286.57 million
Price / Sales
1.32
Cash Flow
$1.13 per share
Price / Cash Flow
8.69
Book Value
$3.80 per share
Price / Book
2.59

Miscellaneous

Outstanding Shares
38,337,000
Free Float
30,670,000
Market Cap
$377.24 million
Optionable
Not Optionable
Beta
1.15

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:VMD) was last updated on 5/30/2026 by MarketBeat.com Staff.
From Our Partners